DarioHealth enters $32.5M credit agreement with Callodine; warrants issued

DarioHealth Corp.

Borrowed $32.5M at closing; may draw up to $17.5M more subject to revenue thresholds and lender discretion.
Loan bears interest at Term SOFR + 7.75%, matures April 2030; secured by substantially all assets.
Issued warrants to purchase 2,114,140 shares at $0.8278; up to $2.5M loan principal convertible at $0.9933 per share.
Prior Loan and Security Agreement with Avenue terminated; proceeds used to satisfy LSA.
Financial covenants include minimum unencumbered liquid assets, total revenue, and Adjusted EBITDA.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.